the role and targeting of immune dysregulation in mds
Published 1 year ago • 98 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
4:27
the role of immune checkpoint inhibitors in mds
-
1:37
the role of the innate immune system in mds & the value of targeting immune signaling pathways
-
2:49
the role of the immune system in the pathophysiology of mds
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
3:10
the role of ngs in mds diagnosis
-
2:33
insights into the results and implications of the commands & imerge studies in lr-mds
-
2:07
emerging targeted treatments for mds
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
7:54
patient/caregiver stories - living with mds
-
2:16
updates in the myelodysplastic syndromes: 2023 best of hematology
-
5:22
magrolimab azacitidine in mds and aml
-
2:06
outcomes & promising treatment options following hma failure in patients with hr-mds
-
1:18
key recurrent mutations in mds
-
1:32
next-generation sequencing for low-risk mds
-
1:34
sequencing of agents in lr-mds
-
1:41
an overview of the mds diagnosis pathway
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies
-
2:08
hematological response to frontline treatment in lr-mds is associated with better os
-
1:18
the importance risk stratification to enable risk-adapted therapy in mds & cmml
-
3:31
relevance of the ipss-r during sct in patients with mds in the molecular classification era
-
1:16
state of the art: mds